Copying and distributing are prohibited without permission of the publisher.

Watermark

Lundbeck to make bond debut after drug news

Headache_Adobe_230x150
By Mike Turner
25 Feb 2020

H Lundbeck, the Danish pharmaceutical company, has mandated banks for a five year debut euro benchmark from its new bond programme, after gaining US regulatory approval for a new migraine treatment.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Mike Turner
25 Feb 2020